Ziprasidone (Avera McKennan Hospital)
Welcome to the PulseAid listing for the Ziprasidone drug offered from Avera McKennan Hospital. This Atypical Antipsychotic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Avera McKennan Hospital |
NON-PROPRIETARY NAME: | ziprasidone hydrochloride |
SUBSTANCE NAME: | ZIPRASIDONE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Atypical Antipsychotic [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
START MARKETING DATE: | 2016-02-09 |
END MARKETING DATE: | 0000-00-00 |
Ziprasidone HUMAN PRESCRIPTION DRUG Details:
Item Description | Ziprasidone from Avera McKennan Hospital |
LABELER NAME: | Avera McKennan Hospital |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 40(mg/1) |
START MARKETING DATE: | 2016-02-09 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 69189-2003_b9538029-9024-43e2-9ca8-35587b95ba10 |
PRODUCT NDC: | 69189-2003 |
APPLICATION NUMBER: | NDA020825 |
Other ZIPRASIDONE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: